Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

2.49USD
13 Dec 2017
Change (% chg)

$0.08 (+3.32%)
Prev Close
$2.41
Open
$2.39
Day's High
$2.55
Day's Low
$2.39
Volume
78,218
Avg. Vol
71,848
52-wk High
$3.67
52-wk Low
$0.88

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Marc Rubin

62 2016 Chairman of the Board

Peter Traber

61 2011 President, Chief Executive Officer, Chief Medical Officer, Director

Jack Callicutt

48 2013 Chief Financial Officer

Harold Shlevin

66 2014 Chief Operating Officer, Secretary

Eliezer Zomer

68 2000 Executive Vice President - Manufacturing and Product Development